Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary

• Guardion Health Sciences Inc GHSI reported a quarterly adjusted loss of $3.71​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of 42 cents. The lone analyst forecast for the quarter was for a loss of 88 cents per share.

• Revenue fell 5.8% to $3.00 million from a year ago; analysts expected $3.12 million.

• Guardion Health Sciences Inc's reported EPS for the quarter was a loss of $3.71​.

• The company reported a quarterly loss of $4.75 million.

• Guardion Health Sciences Inc shares had fallen by 8.9% this quarter and gained 54.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is "hold."

Wall Street's median 12-month price target for Guardion Health Sciences Inc is $40.00

This summary was machine generated from LSEG data May 13 at 10:35 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)